Strategies addressing barriers to clinical trial enrollment of underrepresented populations: A systematic review

Caren Heller, Joyce Balls-Berry, Jill Dumbauld Nery, Patricia J. Erwin, Dawn Littleton, Mimi Kim, Winston P. Kuo

Research output: Contribution to journalReview article

49 Citations (Scopus)

Abstract

Background: Underrepresentation of racial and ethnic minorities in clinical trials remains a reality while they have disproportionately higher rates of health disparities. Objective: The purpose of this study was to identify successful community-engaged interventions that included health care providers as a key strategy in addressing barriers to clinical trial enrollment of underrepresented patients. Design: A systematic review of the literature on interventions addressing enrollment barriers to clinical trials for racial and ethnic minorities was performed in Ovid MEDLINE, EBSCO Megafile, and EBSCO CINAHL. The systematic review identified 360 studies, and 20 were selected using the inclusion criteria. An iterative process extracted information from the eligible studies. Results: The 20 selected studies were analyzed and then grouped by first author, nature of the clinical research initiative, priority populations, key strategies, and study outcomes. Nine of the studies addressed cancer clinical trials and 11 related to chronic medical conditions, including diabetes, hypertension management, and chronic kidney disease. The key strategies employed were categorized according to their presumed impact on barriers incurred at distinct steps in study recruitment: clinical trial awareness, opportunity to participate, and acceptance of enrollment. The strategies were further categorized by whether they would address barriers associated with minority perceptions of the research process and barriers related to how studies were designed and implemented. Conclusion: Multiple and flexible strategies targeting providers and participants at provider sites and within communities might be needed to enroll underrepresented populations into clinical trials.

Original languageEnglish (US)
Pages (from-to)169-182
Number of pages14
JournalContemporary Clinical Trials
Volume39
Issue number2
DOIs
StatePublished - Nov 1 2014

Fingerprint

Clinical Trials
Population
Chronic Renal Insufficiency
Research
MEDLINE
Health Personnel
Outcome Assessment (Health Care)
Hypertension
Health
Neoplasms

Keywords

  • Clinical trials
  • Minority
  • Recruitment

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Strategies addressing barriers to clinical trial enrollment of underrepresented populations : A systematic review. / Heller, Caren; Balls-Berry, Joyce; Nery, Jill Dumbauld; Erwin, Patricia J.; Littleton, Dawn; Kim, Mimi; Kuo, Winston P.

In: Contemporary Clinical Trials, Vol. 39, No. 2, 01.11.2014, p. 169-182.

Research output: Contribution to journalReview article

Heller, Caren ; Balls-Berry, Joyce ; Nery, Jill Dumbauld ; Erwin, Patricia J. ; Littleton, Dawn ; Kim, Mimi ; Kuo, Winston P. / Strategies addressing barriers to clinical trial enrollment of underrepresented populations : A systematic review. In: Contemporary Clinical Trials. 2014 ; Vol. 39, No. 2. pp. 169-182.
@article{7604308245e44181ae0bada28cb1dcad,
title = "Strategies addressing barriers to clinical trial enrollment of underrepresented populations: A systematic review",
abstract = "Background: Underrepresentation of racial and ethnic minorities in clinical trials remains a reality while they have disproportionately higher rates of health disparities. Objective: The purpose of this study was to identify successful community-engaged interventions that included health care providers as a key strategy in addressing barriers to clinical trial enrollment of underrepresented patients. Design: A systematic review of the literature on interventions addressing enrollment barriers to clinical trials for racial and ethnic minorities was performed in Ovid MEDLINE, EBSCO Megafile, and EBSCO CINAHL. The systematic review identified 360 studies, and 20 were selected using the inclusion criteria. An iterative process extracted information from the eligible studies. Results: The 20 selected studies were analyzed and then grouped by first author, nature of the clinical research initiative, priority populations, key strategies, and study outcomes. Nine of the studies addressed cancer clinical trials and 11 related to chronic medical conditions, including diabetes, hypertension management, and chronic kidney disease. The key strategies employed were categorized according to their presumed impact on barriers incurred at distinct steps in study recruitment: clinical trial awareness, opportunity to participate, and acceptance of enrollment. The strategies were further categorized by whether they would address barriers associated with minority perceptions of the research process and barriers related to how studies were designed and implemented. Conclusion: Multiple and flexible strategies targeting providers and participants at provider sites and within communities might be needed to enroll underrepresented populations into clinical trials.",
keywords = "Clinical trials, Minority, Recruitment",
author = "Caren Heller and Joyce Balls-Berry and Nery, {Jill Dumbauld} and Erwin, {Patricia J.} and Dawn Littleton and Mimi Kim and Kuo, {Winston P.}",
year = "2014",
month = "11",
day = "1",
doi = "10.1016/j.cct.2014.08.004",
language = "English (US)",
volume = "39",
pages = "169--182",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Strategies addressing barriers to clinical trial enrollment of underrepresented populations

T2 - A systematic review

AU - Heller, Caren

AU - Balls-Berry, Joyce

AU - Nery, Jill Dumbauld

AU - Erwin, Patricia J.

AU - Littleton, Dawn

AU - Kim, Mimi

AU - Kuo, Winston P.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Background: Underrepresentation of racial and ethnic minorities in clinical trials remains a reality while they have disproportionately higher rates of health disparities. Objective: The purpose of this study was to identify successful community-engaged interventions that included health care providers as a key strategy in addressing barriers to clinical trial enrollment of underrepresented patients. Design: A systematic review of the literature on interventions addressing enrollment barriers to clinical trials for racial and ethnic minorities was performed in Ovid MEDLINE, EBSCO Megafile, and EBSCO CINAHL. The systematic review identified 360 studies, and 20 were selected using the inclusion criteria. An iterative process extracted information from the eligible studies. Results: The 20 selected studies were analyzed and then grouped by first author, nature of the clinical research initiative, priority populations, key strategies, and study outcomes. Nine of the studies addressed cancer clinical trials and 11 related to chronic medical conditions, including diabetes, hypertension management, and chronic kidney disease. The key strategies employed were categorized according to their presumed impact on barriers incurred at distinct steps in study recruitment: clinical trial awareness, opportunity to participate, and acceptance of enrollment. The strategies were further categorized by whether they would address barriers associated with minority perceptions of the research process and barriers related to how studies were designed and implemented. Conclusion: Multiple and flexible strategies targeting providers and participants at provider sites and within communities might be needed to enroll underrepresented populations into clinical trials.

AB - Background: Underrepresentation of racial and ethnic minorities in clinical trials remains a reality while they have disproportionately higher rates of health disparities. Objective: The purpose of this study was to identify successful community-engaged interventions that included health care providers as a key strategy in addressing barriers to clinical trial enrollment of underrepresented patients. Design: A systematic review of the literature on interventions addressing enrollment barriers to clinical trials for racial and ethnic minorities was performed in Ovid MEDLINE, EBSCO Megafile, and EBSCO CINAHL. The systematic review identified 360 studies, and 20 were selected using the inclusion criteria. An iterative process extracted information from the eligible studies. Results: The 20 selected studies were analyzed and then grouped by first author, nature of the clinical research initiative, priority populations, key strategies, and study outcomes. Nine of the studies addressed cancer clinical trials and 11 related to chronic medical conditions, including diabetes, hypertension management, and chronic kidney disease. The key strategies employed were categorized according to their presumed impact on barriers incurred at distinct steps in study recruitment: clinical trial awareness, opportunity to participate, and acceptance of enrollment. The strategies were further categorized by whether they would address barriers associated with minority perceptions of the research process and barriers related to how studies were designed and implemented. Conclusion: Multiple and flexible strategies targeting providers and participants at provider sites and within communities might be needed to enroll underrepresented populations into clinical trials.

KW - Clinical trials

KW - Minority

KW - Recruitment

UR - http://www.scopus.com/inward/record.url?scp=84910083388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910083388&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2014.08.004

DO - 10.1016/j.cct.2014.08.004

M3 - Review article

AN - SCOPUS:84910083388

VL - 39

SP - 169

EP - 182

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

IS - 2

ER -